Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -4.32 % |
3 Month Return | + 12.27 % |
1 Year Return | + 161.87 % |
Market Stats | |
Previous Close | ₹239.25 |
Open | ₹240.00 |
Volume | 69.26K |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹783.79Cr |
P/E Ratio | 15.09 |
PEG Ratio | 0.97 |
Market Cap | ₹783.79 Cr |
P/B Ratio | 21.77 |
EPS | 17.09 |
Dividend Yield | 0 |
Sector | Pharmaceuticals |
ROE | 38.26 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹783.79 Cr | 370.79% | 0.91 | ₹55 Cr | ₹575 Cr | |
NA | ₹136.73 Cr | 9.85% | 0.59 | NA | NA | |
NA | ₹2,410.53 Cr | 173.57% | 0.62 | ₹43 Cr | ₹381 Cr | |
NA | ₹162.20 Cr | 101.48% | 0.58 | NA | NA | |
NA | ₹18,538.81 Cr | 70.96% | 0.77 | -₹472 Cr | ₹2,798 Cr |
Organisation | Wanbury Ltd |
Headquarters | |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Key events for Wanbury Ltd
Wanbury Ltd's shares hit a 5% upper circuit after announcing the launch of two new APIs, Dextromethorphan and Ketamine, alongside a robust pipeline of products. Despite a decline in quarterly profits, the stock has appreciated significantly year-to-date.
Wanbury Secures CEP for Cough Relief Drug - 09 Sep, 2024
Wanbury Ltd. has received a Certificate of Suitability for its cough suppressant Dextromethorphan, allowing sales in Europe. The company faces challenges with declining profits and revenues due to facility upgrades.
Wanbury Shares Rise After USFDA Inspection Success - 23 Aug, 2024
Wanbury Ltd's shares surged after receiving an Establishment Inspection Report from the USFDA with zero observations, indicating compliance with good manufacturing practices. The company also received awards for safety performance.
Wanbury Reports Decline in Sales and Profit - 17 Aug, 2024
Wanbury's June 2024 net sales fell 10.38% to Rs 131.11 crore, with net profit down 77.87% to Rs 1.04 crore. Despite this, shares have gained 11.87% over six months and 237.21% over the past year.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Best in 3 Years
In the last 3 years, WANBURY has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
Best in 1 Year
In the last 1 year, WANBURY has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
Price Rise
In the last 1 year, WANBURY stock has moved up by 161.9%
FII Holding Up
Foreign Institutions have increased holdings from 0.22% to 1.02% in Sep 2024 quarter
Revenue Fall
Revenue is down for the last 2 quarters, 165.89 Cr → 132.05 Cr (in ₹), with an average decrease of 20.4% per quarter
Retail Holding Down
Retail Investor have decreased holdings from 59.98% to 59.20% in Sep 2024 quarter
Profit Down
Netprofit is down for the last 2 quarters, 33.63 Cr → 1.04 Cr (in ₹), with an average decrease of 96.9% per quarter
Promoter Holding Down
Promoters have decreased holdings from 39.79% to 39.77% in Sep 2024 quarter
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 39.77% | ||
Foreign Institutions | 1.02% | 356.34 | |
Mutual Funds | 0% | 0.00 | |
Retail Investors | 59.2% | ||
Others | 0% | 6.25 |
Wanbury Ltd in the last 5 years
Lowest (-105.12x)
July 15, 2021
Today (15.09x)
November 1, 2024
Industry (57.19x)
November 1, 2024
Highest (146.91x)
September 29, 2023
Wanbury Ltd’s net profit fell -77.83% since last year same period to ₹1.04Cr in the Q1 2024-2025. On a quarterly growth basis, Wanbury Ltd has generated -96.91% fall in its net profits since last 3-months.
Read More about Earnings ResultsBearish
Neutral
Bullish
Wanbury Ltd is currently in a Bullish trading position according to technical analysis indicators.
Wanbury Ltd (WANBURY) share price today is ₹241.31
Wanbury Ltd is listed on NSE
Wanbury Ltd is listed on BSE
PE Ratio of Wanbury Ltd is 15.09
PE ratio = Wanbury Ltd Market price per share / Wanbury Ltd Earnings per share
Today’s traded volume of Wanbury Ltd(WANBURY) is 69.26K.
Today’s market capitalisation of Wanbury Ltd(WANBURY) is ₹783.79Cr.
Wanbury Ltd(WANBURY | Price |
---|---|
52 Week High | ₹290.2 |
52 Week Low | ₹87.9 |
Wanbury Ltd(WANBURY) share price is ₹241.31. It is down -16.85% from its 52 Week High price of ₹290.2
Wanbury Ltd(WANBURY) share price is ₹241.31. It is up 174.53% from its 52 Week Low price of ₹87.9
Wanbury Ltd(WANBURY | Returns |
---|---|
1 Day Returns | 2.06% |
1 Month Returns | -4.32% |
3 Month Returns | 12.27% |
1 Year Returns | 161.87% |